C5AR1 and COVID-19: Here we demonstrated that both anaphylatoxins C3a and C5a were highly detectable in patient plasma with severe or critical COVID-19, which was previously associated with worsening of injury in the airway epithelium and with inflammasome activation in immune cells and lung tissues (49, 50).